← Back to Search

Device

Automated Variable Pressure Insufflation for Migraine

N/A
Waitlist Available
Research Sponsored by Nocira, LLC
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 hours post treatment
Awards & highlights

Study Summary

This trial is testing a new migraine treatment against a sham treatment. Participants will be randomly assigned to one of the two treatments and followed for 24 hours after treatment.

Eligible Conditions
  • Migraine

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 hours post treatment
This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 hours post treatment for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Pain Freedom Rates - active

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Active TreatmentExperimental Treatment1 Intervention
The AVPI device software is set in "active mode" which delivers the therapy to the subject. Neither the subject or the investigator is aware of which mode is being used.
Group II: Sham treatmentPlacebo Group1 Intervention
The AVPI device software is set in "sham mode" which does not deliver the therapy to the subject. Neither the subject or the investigator is aware of which mode is being used.

Find a Location

Who is running the clinical trial?

Nocira, LLCLead Sponsor
1 Previous Clinical Trials
80 Total Patients Enrolled
1 Trials studying Migraine
80 Patients Enrolled for Migraine
David GeorgeStudy DirectorNocira, LLC

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Automated Variable Pattern Insufflator Device (AVPI) for the Acute Treatment of Migraine
2020. "Automated Variable Pattern Insufflator Device (AVPI) for the Acute Treatment of Migraine". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04584762.
All > Migraine
~16 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top